Genetic determinants in hepatitis C virus-associated mixed cryoglobulinemia: role of polymorphic variants of BAFF promoter and Fcγ receptors (Q43036468)

From Wikidata

Jump to navigation Jump to search

scientific article published in May 2011

Language	Label	Description	Also known as
English	Genetic determinants in hepatitis C virus-associated mixed cryoglobulinemia: role of polymorphic variants of BAFF promoter and Fcγ receptors	scientific article published in May 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Genetic determinants in hepatitis C virus-associated mixed cryoglobulinemia: role of polymorphic variants of BAFF promoter and Fcγ receptors (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Hepatitis C virus

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Anna Linda Zignego

12

object named as

Anna Linda Zignego

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

author name string

Alessia Piluso

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Carlo Giannini

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Patrizio Caini

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Elisa Fognani

5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Monica Monti

6

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Antonio Petrarca

7

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Jessica Ranieri

8

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Giulia Razzolini

9

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Valentina Froio

10

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

publication date

1 May 2011

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Arthritis & Rheumatology

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

63

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

1446-1451

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Hepatitis C virus-related lymphoproliferative disorders: an overview.

1 reference

https://api.crossref.org/works/10.1002%2FART.30274

21 January 2018

Analysis of Hepatitis C Virus Hypervariable Region 1 Sequence from Cryoglobulinemic Patients and Associated Controls

1 reference

https://api.crossref.org/works/10.1002%2FART.30274

21 January 2018

Hepatitis C virus infection, mixed cryoglobulinemia and BLyS upregulation: targeting the infectious trigger, the autoimmune response, or both?

1 reference

https://api.crossref.org/works/10.1002%2FART.30274

21 January 2018

Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases.

1 reference

https://api.crossref.org/works/10.1002%2FART.30274

21 January 2018

Elevated serum B-lymphocyte stimulator levels in patients with familial lymphoproliferative disorders.

1 reference

https://api.crossref.org/works/10.1002%2FART.30274

21 January 2018

Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and severe liver disease.

1 reference

https://api.crossref.org/works/10.1002%2FART.30274

21 January 2018

Association between polymorphism in IgG Fc receptor IIIa coding gene and biological response to infliximab in Crohn's disease.

1 reference

https://api.crossref.org/works/10.1002%2FART.30274

21 January 2018

FCGR3A and FCGR2A polymorphisms may not correlate with response to alemtuzumab in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FART.30274

21 January 2018

Efficacy of low-dose rituximab for mixed cryoglobulinemia

1 reference

https://api.crossref.org/works/10.1002%2FART.30274

21 January 2018

Rituximab-dependent cytotoxicity by natural killer cells: influence of FCGR3A polymorphism on the concentration-effect relationship.

1 reference

https://api.crossref.org/works/10.1002%2FART.30274

21 January 2018

Role of the HLA class II: HCV-related disorders.

1 reference

https://api.crossref.org/works/10.1002%2FART.30274

21 January 2018

Identifiers

10.1002/ART.30274

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43036468&oldid=1978278231"